Company Search:
Advanced Search
Sponsored Links
Ind-Swift Laboratories Limited Company Snapshot
Ind-Swift Laboratories Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ind-Swift Laboratories Limited with three other companies in this sector in INDIA : Astrazeneca Pharma India Ltd (2020 sales of 8.32 billion Indian Rupees [US$112.88 million] of which 100% was Healthcare), Morepen Laboratories Limited (8.53 billion Indian Rupees [US$115.76 million] of which 100% was Pharmaceutical segment), and Neuland Laboratories Limited (7.63 billion Indian Rupees [US$103.50 million] of which 100% was Manufacture of active pharmaceutical ing).

Sales Analysis. Ind-Swift Laboratories Limited reported sales of 7.80 billion Indian Rupees (US$105.80 million) for the fiscal year ending March of 2020. This represents an increase of 3.0% versus 2019, when the company's sales were 7.57 billion Indian Rupees .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ind-Swift Laboratories Limited
  Stock Performance Chart for Ind-Swift Laboratories Limited
  Stock Data: Recent Stock Performance:
  Current Price (9/25/2020): 45.05
(Figures in Indian Rupees )
1 Week 3.9%   13 Weeks 24.6%  
4 Weeks 34.3%   52 Weeks 4.4%  
Ind-Swift Laboratories Limited Key Data:
  Ticker: INDSWFTLAB Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 7,796,431,000
(Year Ending Jan 2021).
Employees: 1,469
  Currency: Indian Rupees Market Cap: 2,661,865,701
  Fiscal Yr Ends: March Shares Outstanding: 59,086,919
  Share Type: Ordinary Closely Held Shares: 40,774,493
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.